| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |